T Helper-independent activation of human CD8+ cells: The role of CD28 costimulation

Scandinavian Journal of Immunology

Volumn 44, Issue 1, 1996, Pages 21-29

  Van Gool, S W ^a,b   Zhang, Yiqun ^a   Kasran, A ^a   De Boer, M ^c   Ceuppens, J L ^a,d  

^a Laboratory of Experimental Cancer Research   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c INNOGENETICS   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 2;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0029889457     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-82.x     Document Type: Article

References (43)

1. Gill RG. T-cell-T-cell collaboration in allograft responses. Curr Opin Immunol 1993;5:782-7.
2. Cantor H, Boyse EA. Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly + cells in the generation of killer activity. J Exp Med 1975;141:1390-9.
3. Wagner H, Rolinghoff M. TT cell interactions during in vitro cytotoxic allograft responses. I. Soluble products from activated Ly1 +T cells trigger autonomously antigen-primed Ly23 + T cells to cell proliferation and cytolytic activity. J Exp Med 1978;148:1523-38.
4. + cells via CD3. Scand J Immunol 1987;26:197-205.
5. + T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation. Tissue Antigens 1991;37:26-32.
6. + precursor subpopulations. J Immunol 1992;149:2489-95.
7. + precursor subpopulations. J Immunol 1993;151:2895-903.
8. + helper cell requirement in cytotoxic T lymphocyte responses. Eur J Immunol 1988;18:219-23.
9. + cytotoxic T lymphocytes by dendritic cells. J Exp Med 1987;166:182-94.
10. + helper T cells. J Exp Med 1990;171:1315-332.
11. + CTLs from naive precursors. J Immunol 1994;153:996-1003.
12. + 8 + thymocytes. J Immunol 1992;149:3217-24.
13. + cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 1993;177:1791-6.
14. Chen L, Ashe S, Brady WA et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992;71:1093-102.
15. + T cells by B7-transfected melanoma cells. Science 1993;259:368-70.
16. Buller RML, Holmes KL, Hugin A, Frederickson TN, Morse III HC. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 1987;328:77-9.
17. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Ann Rev Immunol 1993;11:191-212.
18. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15:321-31.
19. Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9.
20. Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B72: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909-11.
21. Freeman GJ, Borriello F, Hodes RJ et al. Murine B72, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med 1993;178:2185-92.
22. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-9.
23. Van Gool SW, de Boer M, Ceuppens JL. CD28 ligation by MoAb or B7/BB1 provides an accessory signal for the CsA-resistant generation of cytotoxic T cell activity. J Immunol 1993;150:3254-63.
24. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 1992;175:353-60.
25. Van Gool SW, Ceuppens JL, Walter H, de Boer M. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation. Blood 1994;83:176-83.
26. + T lymphocytes. J Immunol 1994;152:1523-31.
27. Shahinian A, Pfeffer K, Lee KP et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993;261:609-12.
28. Van Gool SW, Kasran A, Wallays G, de Boer M, Ceuppens JL. Accessory signalling by B7-1 for T cell activation induced by anti-CD2: evidence for IL-2-independent CTL generation and CsA-resistant cytokine production. Scand J Immunol 1995;41:23-30.
29. de Boer M, Parren P, Dove J, Ossendorp P, van der Horst G, Reeder J. Functional characterization of a novel anti-B7 monoclonal antibody. Eur J Immunol 1992;22:3071-5.
30. Warmerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ. Molecular basis for a polymorphism of human Fcg receptor II (CD32). J Exp Med 1990;172:19-25.
31. Baroja ML, Ceuppens JL. More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes. J Immunol Methods 1987;98:267-70.
32. Van Gool SW, de Boer M, Ceuppens JL. The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction. J Exp Med 1994;179:715-20.
33. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 1987;7:4472-81.
34. van Seventer GA, Shimizu Y, Shaw S. Roles of multiple accessory molecules in T-cell activation. Curr Opin Immunol 1991;3:294-303.
35. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993;90:11059-63.
36. Nickoloff BJ, Turka LA. Immunological functions of non-professional antigen-presenting cells: new insights from studies of Tcell interactions with keratinocytes. Immunol Today 1994;15:464-9.
37. Siekierka JJ, Sigal NH. FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond. Curr Opin Immunol 1992;4:548-52.
38. Stohl W, Tovar Z, Talal N. Generation of cytolytic activity with anti-CD3 monoclonal antibodies involves both IL-2- independent and-dependent components. J Immunol 1990;144:3718-25.
39. Widmer MB, Grabstein KH. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 1987;326:795-8.
40. Takai Y, Wong G, Clark S, Burakoff S, Herrmann S. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 1988;140:508-12.
41. Chen W, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991;147:528-34.
42. Chen L, Tourvieille B, Burns G et al. Interferon: a cytotoxic T lymphocyte differentiation signal. Eur J Immunol 1986;16:767-70.
43. Wecker H, Auchincloss H. Cellular mechanisms of rejection. Curr Opin Immunol 1992;4:561-6.